VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price was down 9.1% during trading on Friday . The company traded as low as C$0.20 and last traded at C$0.20. Approximately 104,000 shares changed hands during mid-day trading, an increase of 6% from the average daily volume of 97,875 shares. The stock had previously closed at C$0.22.
VentriPoint Diagnostics Trading Down 9.1 %
The company has a debt-to-equity ratio of 217.41, a quick ratio of 6.67 and a current ratio of 1.17. The business has a 50 day moving average of C$0.21 and a two-hundred day moving average of C$0.24. The firm has a market capitalization of C$31.36 million, a price-to-earnings ratio of -6.67 and a beta of 0.43.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- How to Choose Top Rated Stocks
- Why Call Options Volume for These 2 Stocks Spiked Together
- The 3 Best Blue-Chip Stocks to Buy Now
- MarketBeat Week in Review – 7/22 – 7/26
- Golden Cross Stocks: Pattern, Examples and Charts
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
